BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Nov. 18, 2020

Nov. 18, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagio, Amarin, Aphios, Ardigen, Asahi Kasei, Ascletis, Aum Biosciences, Baymedica, Biocollective, Biospecifics, Caraway, Caribou, Clarametyx, Endo, Generex, Indivumed, Inmed, Insel Gruppe, Mymetics, Newsoara, Obsidian, Probiogen, Relief, Revive, Sunshine.
Read More

Other news to note for Nov. 17, 2020

Nov. 17, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ab Medica, Brain Scientific, Burning Rock Biotech, Clalit, Diomics, Edap Tms, Elitechgroup, Healthy.io, In2bones Global, Infinity Angioplasty Balloon, Invibio, Irras, Itamar Medical, Kohlberg Kravis Roberts, Life Image, Medrhythms, Myriad Genetics, Nanostring Technologies, Pear Therapeutics, Pharmajet, Premier, Radiomedix, Roux Institute, SyntheticMR, Sysmex, Tempus, Vect-Horus, Zebra Medical Vision, Zeus Health, Zoll.
Read More

Other news to note for Nov. 17, 2020

Nov. 17, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Abpro, Aikido, Altimmune, Amcure, Aravive, Astrazeneca, Atyr, Biontech, Biovaxys Technology, Bristol Myers Squibb, CCT Research, Collplant, CSL, Curevac, Farmacore, Guangzhou Baiyunshan, Hinova, Hitgen, Immuron, Johnson & Johnson, Kiadis, Lonza, Lung, Mallinckrodt, Nanoviricides, Noxopharm, Origimed, PDS, Pfizer, Pluristyx, Prestige, Qiagen, Recce, Reven, Selva, Sumitomo Dainippon, Sumitovant, Taiho, Takeda, Teva, Tscan, Urovant Sciences, Vaxart, Wuxi Advanced, Wuxi Apptec, Xoma, Xortx.
Read More

Other news to note for Nov. 17, 2020

Nov. 17, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Almac, Antibe, Biomarin, Bridgebio, Bristol, Concert, Curevac, Deep Genomics, Evotec, Evox, Foresee, Genscience, Insilico, Lilly, Medison, Merck, Moderna, Myokardia, Novartis, Ocuphire, OS Therapies, Pear, Reveragen, Samsung, Storm, Treefrog, Tris.
Read More

Other news to note for Nov. 16, 2020

Nov. 16, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspen Dental Management, B. Braun Melsungen, Baxter, Cape Biologix, Clearchoice, Diabeloop, Grifols, Inno-3B, Intralink-Spine, Masimo, Medicrea, Medtronic, Nuprobe, Plantform, Procept Biorobotics, Qiagen, Start Codon, Sun Capital Partners, Terumo.
Read More

Other news to note for Nov. 16, 2020

Nov. 16, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 9 Meters, Abpro, Aeterna, Agbiome, AIkido Amag, Assembly, Biohaven, Bone, Catalent, Covis, Dicerna, Door, Elevatebio, IEH, Innocan, Johnson & Johnson, Kala, Lead, Lifeedit, Lilly, Merck & Co., Minoryx, Mylan, Pfizer, Pharvaris, Prime, PTC, Receptor, Roche, Synthetic Biologics, Vertex, Viatris, Vivus, Xoma, Xortx.
Read More

Other news to note for Nov. 13, 2020

Nov. 13, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apollo Health, Aziyo Biologics, Circle Medical Technologies, Clinical Genomics, Echosens, Fio, Gelesis, Iwatani, Precision Healing, Premier, Readout Health, Relay Medical, Sanara, Sintx, Stemonix, Stryker, United Wound and Skin Solutions, Well Health Technologies, Wright Medical.
Read More

Other news to note for Nov. 13, 2020

Nov. 13, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Annexon, Atara, Axcella, Biocryst, C4, Calcimedica, Gelesis, Harpoon, Ionis, Medicinova, Orchard, Orphan Technologies, Puretech, Retrophin, Roche, Silverback, Sumitovant, Urovant.
Read More

Orchard presents new HSC gene therapy research programs in dementia and Crohn's disease

Nov. 13, 2020

Other news to note for Nov. 12, 2020

Nov. 12, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied DNA Sciences, Avicenna.AI, Becton Dickinson, Canon Medical Systems, Cb Scientific, Cubex, Decision Diagnostics, Djo, Fedoc, Isohelix, Mindray North America, Perspectum, Precision Genetics, Stryker, Tidepool, Virusight Diagnostic, Vizient, Zoll Medical.
Read More
Previous 1 2 … 328 329 330 331 332 333 334 335 336 … 1400 1401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing